BR9811028A - Composto, composição farmacêutica, e, processos de tratamento de uma doença de agregação de plaquetas e para a preparação de um composto - Google Patents
Composto, composição farmacêutica, e, processos de tratamento de uma doença de agregação de plaquetas e para a preparação de um compostoInfo
- Publication number
- BR9811028A BR9811028A BR9811028-4A BR9811028A BR9811028A BR 9811028 A BR9811028 A BR 9811028A BR 9811028 A BR9811028 A BR 9811028A BR 9811028 A BR9811028 A BR 9811028A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- processes
- preparation
- treating
- pharmaceutical composition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000004931 aggregating effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- 150000003852 triazoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702774A SE9702774D0 (sv) | 1997-07-22 | 1997-07-22 | Novel compounds |
| PCT/SE1998/001394 WO1999005144A1 (en) | 1997-07-22 | 1998-07-15 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9811028A true BR9811028A (pt) | 2000-08-01 |
Family
ID=20407805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9811028-4A BR9811028A (pt) | 1997-07-22 | 1998-07-15 | Composto, composição farmacêutica, e, processos de tratamento de uma doença de agregação de plaquetas e para a preparação de um composto |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6166022A (enExample) |
| EP (1) | EP0998475B1 (enExample) |
| JP (1) | JP2001510843A (enExample) |
| KR (1) | KR20010022084A (enExample) |
| CN (1) | CN1270591A (enExample) |
| AT (1) | ATE216390T1 (enExample) |
| AU (1) | AU8370798A (enExample) |
| BR (1) | BR9811028A (enExample) |
| CA (1) | CA2296426A1 (enExample) |
| DE (1) | DE69804966T2 (enExample) |
| EE (1) | EE200000048A (enExample) |
| HU (1) | HUP0003826A3 (enExample) |
| ID (1) | ID25856A (enExample) |
| IL (1) | IL134111A0 (enExample) |
| IS (1) | IS5352A (enExample) |
| NO (1) | NO20000313L (enExample) |
| PL (1) | PL338181A1 (enExample) |
| SE (1) | SE9702774D0 (enExample) |
| SK (1) | SK188299A3 (enExample) |
| TR (1) | TR200000152T2 (enExample) |
| WO (1) | WO1999005144A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9702773D0 (sv) * | 1997-07-22 | 1997-07-22 | Astra Pharma Prod | Novel compounds |
| ID27127A (id) * | 1998-02-17 | 2001-03-01 | Astrazeneca Uk Ltd | SENYAWA-SENYAWA TRIAZOLO (4,5-d) PIRIMIDINA YANG BARU |
| ATE263146T1 (de) | 1999-09-09 | 2004-04-15 | Chirotech Technology Ltd | Substituierte cyclopentene, verfahren zu deren herstellung un deren verwendung als chirale gerüste |
| SE9904129D0 (sv) * | 1999-11-15 | 1999-11-15 | Astra Pharma Prod | Novel compounds |
| AR039558A1 (es) * | 2000-08-21 | 2005-02-23 | Inspire Pharmaceuticals Inc | Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular |
| US7018985B1 (en) | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| US6897201B2 (en) | 2000-08-21 | 2005-05-24 | Inspire Pharmaceuticals, Inc. | Compositions and methods for the treatment of glaucoma or ocular hypertension |
| US7115585B2 (en) * | 2000-08-21 | 2006-10-03 | Inspire Pharmaceuticals, Inc. | Compositions for treating epithelial and retinal tissue diseases |
| US7452870B2 (en) * | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
| US7132408B2 (en) * | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| US7435724B2 (en) * | 2002-02-27 | 2008-10-14 | Inspire Pharmaceutical, Inc. | Degradation-resistant mononucleoside phosphate compounds |
| CA2540214A1 (en) | 2003-10-03 | 2005-04-14 | Portola Pharmaceuticals, Inc. | 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| KR20060113699A (ko) | 2003-10-03 | 2006-11-02 | 포톨라 파마슈티컬스, 인코포레이티드 | 치환된 이소퀴놀리논 |
| US7504497B2 (en) | 2003-10-21 | 2009-03-17 | Inspire Pharmaceuticals, Inc. | Orally bioavailable compounds and methods for inhibiting platelet aggregation |
| US7749981B2 (en) | 2003-10-21 | 2010-07-06 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound |
| US7335648B2 (en) | 2003-10-21 | 2008-02-26 | Inspire Pharmaceuticals, Inc. | Non-nucleotide composition and method for inhibiting platelet aggregation |
| US7368438B2 (en) | 2003-10-21 | 2008-05-06 | Inspire Pharmaceuticals, Inc. | Non-nucleotide compositions and method for inhibiting platelet aggregation |
| ZA200702688B (en) | 2004-09-29 | 2008-06-25 | Portola Pharm Inc | Substituted 2H-1,3-benzoxazin-4-(3H)-ones |
| US7932376B2 (en) | 2005-05-05 | 2011-04-26 | Inspire Pharmaceuticals, Inc. | Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation |
| WO2007020935A1 (ja) * | 2005-08-17 | 2007-02-22 | Ono Pharmaceutical Co., Ltd. | Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤 |
| JP5509406B2 (ja) | 2005-11-03 | 2014-06-04 | ポートラ ファーマシューティカルズ， インコーポレイテッド | ［４−（６−ハロ−７−置換−２，４−ジオキソ−１，４−ジヒドロ−２ｈ−キナゾリン−３−イル）−フェニル］−５−クロロ−チオフェン−２−イル−スルホニル尿素、ならびにそれに関連する形態および方法 |
| US7566722B2 (en) | 2006-10-31 | 2009-07-28 | Janssen Pharmaceutica, N.V. | Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists |
| US9725479B2 (en) | 2010-04-22 | 2017-08-08 | Ionis Pharmaceuticals, Inc. | 5′-end derivatives |
| IN2012CN10271A (enExample) * | 2010-05-27 | 2015-04-10 | Reddy’S Lab Ltd Dr | |
| US9458244B2 (en) | 2012-12-28 | 2016-10-04 | Abbvie Inc. | Single chain multivalent binding protein compositions and methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4742064A (en) * | 1985-09-10 | 1988-05-03 | Regents Of The University Of Minnesota | Antiviral carbocyclic analogs of xylofuranosylpurines |
| GB8826205D0 (en) * | 1988-11-09 | 1988-12-14 | Wellcome Found | Heterocyclic compounds |
| CA2154681A1 (en) * | 1993-02-03 | 1994-08-18 | Mark David Erion | Adenosine kinase inhibitors comprising lyxofuranosyl derivatives |
| PL182680B1 (pl) * | 1995-07-11 | 2002-02-28 | Astrazeneca Ab | Nowe inhibitory skupiania się płytek krwi |
-
1997
- 1997-07-22 SE SE9702774A patent/SE9702774D0/xx unknown
-
1998
- 1998-07-15 PL PL98338181A patent/PL338181A1/xx not_active Application Discontinuation
- 1998-07-15 IL IL13411198A patent/IL134111A0/xx unknown
- 1998-07-15 BR BR9811028-4A patent/BR9811028A/pt not_active IP Right Cessation
- 1998-07-15 KR KR1020007000653A patent/KR20010022084A/ko not_active Withdrawn
- 1998-07-15 DE DE69804966T patent/DE69804966T2/de not_active Expired - Fee Related
- 1998-07-15 AU AU83707/98A patent/AU8370798A/en not_active Abandoned
- 1998-07-15 US US09/155,567 patent/US6166022A/en not_active Expired - Fee Related
- 1998-07-15 TR TR2000/00152T patent/TR200000152T2/xx unknown
- 1998-07-15 EE EEP200000048A patent/EE200000048A/xx unknown
- 1998-07-15 HU HU0003826A patent/HUP0003826A3/hu unknown
- 1998-07-15 JP JP2000504140A patent/JP2001510843A/ja active Pending
- 1998-07-15 AT AT98934108T patent/ATE216390T1/de active
- 1998-07-15 WO PCT/SE1998/001394 patent/WO1999005144A1/en not_active Ceased
- 1998-07-15 EP EP98934108A patent/EP0998475B1/en not_active Expired - Lifetime
- 1998-07-15 CN CN98809157A patent/CN1270591A/zh active Pending
- 1998-07-15 SK SK1882-99A patent/SK188299A3/sk unknown
- 1998-07-15 CA CA002296426A patent/CA2296426A1/en not_active Abandoned
- 1998-07-15 ID IDW20000145D patent/ID25856A/id unknown
-
2000
- 2000-01-19 IS IS5352A patent/IS5352A/is unknown
- 2000-01-21 NO NO20000313A patent/NO20000313L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL338181A1 (en) | 2000-10-09 |
| CN1270591A (zh) | 2000-10-18 |
| NO20000313D0 (no) | 2000-01-21 |
| IL134111A0 (en) | 2001-04-30 |
| ID25856A (id) | 2000-11-09 |
| WO1999005144A1 (en) | 1999-02-04 |
| TR200000152T2 (tr) | 2000-07-21 |
| HUP0003826A3 (en) | 2001-11-28 |
| SE9702774D0 (sv) | 1997-07-22 |
| HUP0003826A2 (hu) | 2001-04-28 |
| EP0998475B1 (en) | 2002-04-17 |
| JP2001510843A (ja) | 2001-08-07 |
| DE69804966D1 (de) | 2002-05-23 |
| NO20000313L (no) | 2000-03-22 |
| IS5352A (is) | 2000-01-19 |
| EE200000048A (et) | 2000-10-16 |
| DE69804966T2 (de) | 2002-11-07 |
| CA2296426A1 (en) | 1999-02-04 |
| ATE216390T1 (de) | 2002-05-15 |
| EP0998475A1 (en) | 2000-05-10 |
| US6166022A (en) | 2000-12-26 |
| SK188299A3 (en) | 2000-08-14 |
| AU8370798A (en) | 1999-02-16 |
| KR20010022084A (ko) | 2001-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9810802A (pt) | Composto, composição farmacêutica, e, processos para a preparação de um composto, e para tratamento de uma doença de agregação de plaquetas | |
| BR9811028A (pt) | Composto, composição farmacêutica, e, processos de tratamento de uma doença de agregação de plaquetas e para a preparação de um composto | |
| BR9811022A (pt) | Composto, composição farmacêutica, e, processo para preparação de um composto | |
| ATE242783T1 (de) | Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten | |
| BRPI9915883B8 (pt) | "composto de triazolo [ 4,5-d] pirimidina, e, composição farmacêutica" | |
| BR9714082A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto. | |
| BRPI0215312B8 (pt) | composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto | |
| BR9911488A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| BR9909565A (pt) | Derivados bicìclicos do ácido hidroxâmico | |
| BRPI0116237B8 (pt) | "composto de sulfamida, composição farmacêutica contendo o mesmo e seu uso como medicamento antagonista de receptor de endotelina". | |
| IL81002A0 (en) | Pyrazoline derivatives,processes for their preparation and pesticidal compositions containing the same | |
| BG103417A (en) | Condensed pyrimidine bicyclic derivatives | |
| BR9907934A (pt) | Composto, composição farmacêutica, e, processo para a preparação do composto | |
| BR9812492A (pt) | Composto, uso do mesmo, formulação farmacêutica, e, processos para o tratamento de uma doença cardiovascular, para o tratamento de uma vasoconstrição, e para a preparação de compostos | |
| AR002268A1 (es) | Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas. | |
| DE68906609D1 (de) | Dopamin-vorlaeufer. | |
| IL102038A0 (en) | Substituted diaminophthalimides and analogues | |
| UA48958C2 (uk) | 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі | |
| IL112999A0 (en) | Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing them | |
| ATE251162T1 (de) | Triazolo(4,5-d)pyrimidin-verbindungen | |
| BR9812120A (pt) | Derivados de 9h-1, 3-dioxolo/4, 5-h// 2,3 /benzodiazepina 8, composição farmacêutica eprocesso para sua preparação | |
| FR2766487B1 (fr) | Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant | |
| BR9913601A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processo para a preparação de compostos | |
| SE0004099D0 (sv) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A, 5A, 6A, 7A, 8A E 9A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007. |